There are 3397 resources available
725MO - Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3-positive (+) tumours: Focus on neuroendocrine carcinomas
Presenter: Valentina Gambardella
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
825O - Genomic traits of therapeutic response to anti-PD-1 therapy in peripheral T cell lymphoma
Presenter: Ning Lou
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA8 and LBA9
Presenter: Krishnansu Tewari
Session: Presidential 2
Resources:
Slides
Webcast
Invited Discussant 1184MO, 1185MO and 725MO
Presenter: Sara De Dosso
Session: Mini oral session - NETs and endocrine tumours
Resources:
Slides
Webcast
826O - A single-arm, multicenter clinical study of radiotherapy combined with toripalimab in stage I/II extranodal NK/T cell lymphoma
Presenter: Ming Jiang
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Conclusion
Presenter: Gregor Cuzak
Session: How does digitalisation help personalised care throughout the patient journey?
Resources:
Slides
Webcast
Invited Discussant 824O, 825O and 824O
Presenter: Olivier Casasnovas
Session: Proffered paper session - Haematological malignancies
Resources:
Slides
Webcast
1186MO - A prospective phase II single-arm trial on neoadjuvant peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE followed by surgery for pancreatic neuroendocrine tumors (NeoLuPaNET)
Presenter: Stefano Partelli
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
LBA10 - Sotorasib plus panitumumab versus standard-of-care for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC): CodeBreak 300 phase III study
Presenter: Filippo Pietrantonio
Session: Presidential 2
Resources:
Abstract
Slides
Webcast
2212MO - Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?
Presenter: Allan Hackshaw
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast